- October 24, 2025 - Rose Pharma Inc., a clinical-stage biopharmaceutical company developing ROSE-010, a rapid-onset, short-duration GLP-1 therapy targeting both weight management and acute IBS pain, today announced that Chief Executive Officer Enda Kenny, PhD will present data from its recent clinical trial in weight management at #ObesityWeek2025 (sponsored by The Obesity Society) on Tuesday, November 4, 2025 at 7:30 p.m
The safety of NAD+ injection has not been evaluated in women who are breastfeeding or children
Doctors should look at each persons needs and plan their supplements carefully
If you get it from other countries, it could be [a peptide], but it could just be saline or something bad
5-Amino-1MQ (5-Amino-1-methylquinolinium) is a small molecule that stops NNMT (Nicotinamide N-methyltransferase) from working
Retrieved from Duak, N